Molecular hydrogen as an adjuvant therapy may be associated with increased oxygen saturation and improved exercise tolerance in a COVID-19 patient.
Ram B Singh, Ghazi Halabi, Ghizal Fatima, Richa H Rai, Alexander T Tarnava, Tyler W LeBaron · Clinical case reports · 2021
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In Administration of molecular hydrogen dissolved in water to patient with COVID-19-like symptoms may improve oxygen levels and exercise capacity, five minutes after H₂ treatment in the morning, mean oxygen saturation measured over the five‐day period increased from 92.6% to 97.2%, and then slowly decreased to 96.4%, 95%, and 93.4% after 30, 45, and 60 min, respectively (Figure 1A ). These findings add human evidence supporting molecular hydrogen's therapeutic potential to influence exercise performance and recovery.
What the Findings Mean
H2HUBB reviewed how hydrogen-rich water affected the outcomes measured in Administration of molecular hydrogen dissolved in water to patient with COVID-19-like symptoms may improve oxygen levels and exercise capacity. Five minutes after H₂ treatment in the morning, mean oxygen saturation measured over the five‐day period increased from 92.6% to 97.2%, and then slowly decreased to 96.4%, 95%, and 93.4% after 30, 45, and 60 min, respectively (Figure 1A ).
What the Researchers Studied
The researchers studied Administration of molecular hydrogen dissolved in water to patient with COVID-19-like symptoms may improve oxygen levels and exercise capacity.
What Effects Did Molecular Hydrogen Have?
Source-reported hydrogen exposure: 16 mg H₂/day source-reported; 200 mL hydrogen-rich water/day; dissolved H₂ concentration was not sufficiently reported, so H2HUBB did not estimate milligrams of H₂. Five minutes after H₂ treatment in the morning, mean oxygen saturation measured over the five‐day period increased from 92.6% to 97.2%, and then slowly decreased to 96.4%, 95%, and 93.4% after 30, 45, and 60 min, respectively (Figure 1A ). The authors concluded that 5 Treatment with HRW may enhance oxygen saturation in patients with hypoxia, as presented in this case study. Although the exact molecular mechanism of how hydrogen therapy provides benefits to COVID‐19 patients is not known, several mechanisms have previously been suggested.
Why These Findings Matter
These findings add human evidence supporting molecular hydrogen's therapeutic potential to influence exercise performance and recovery and contribute to the growing body of molecular-hydrogen research.
How Strong Is This Evidence?
This is human clinical evidence from a case report. H2HUBB interprets the findings in the context of the study design, sample, comparator, and measured outcomes rather than using one publication as a verdict on hydrogen therapy.
Technical Study Details
H2HUBB classifies this publication as case report with human clinical evidence. The research population or model was Administration of molecular hydrogen dissolved in water to patient with COVID-19-like symptoms may improve oxygen levels and exercise capacity. The hydrogen delivery method was hydrogen-rich water. The source-reported hydrogen exposure was 16 mg H₂/day source-reported; 200 mL hydrogen-rich water/day; dissolved H₂ concentration was not sufficiently reported, so H2HUBB did not estimate milligrams of H₂.
Limitations and Safety
No separate limitations or safety findings were identified in the current-study source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.